Compare IDEXX Laboratories, Inc. (IDXX) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Unity Software Inc — how do they compare? IDEXX Laboratories, Inc. trades at $573.57 (market cap $46.22B), while Unity Software Inc trades at $43.67 (market cap $19.31B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.4× Unity Software Inc's market cap, and Unity Software Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | U | |
|---|---|---|
Market Cap | $46.22B | $19.31B |
Sector | Health | Technology |
52-Week High | $766.68 | $49.47 |
52-Week Low | $526.44 | $17.13 |
Enterprise Value | $47.12B | $19.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $595.76, up 1.55% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $4.27 versus $3.94 expected, driven by 9% organic revenue growth. The company raised full-year EPS guidance to $14.69–14.94, reflecting robust demand in companion animal diagnostics. Valuation ratios remain elevated with a P/E of 41.23, supported by high profitability margins including a net income margin of 25.03% and ROE of 74.21%.
Outlook is positive given consistent earnings beats, international expansion, and product innovation, but risks include premium valuation sensitivity and competitive pressures. The consensus price target of $683.33 implies 14.7% upside, with 57% of analysts rating it Buy. Investors should weigh growth durability against high multiples.
Unity Software (U) trades at $43.10, up 0.23% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $47.45. Recent Q2 2026 earnings beat expectations, with revenue growth of 24% year-over-year, driven by strong Vector advertising platform performance. The company reported positive operating cash flow of $422.96 million in 2025, though net income remains negative at -$402.77 million.
The outlook is mixed: strong revenue growth and analyst optimism support upside potential, but persistent net losses and high valuation ratios (P/S 9.33, EV/EBITDA 134.62) pose risks. Investors should weigh the company's path to GAAP profitability against competitive pressures in the software sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
